Arcus Biosciences (RCUS) Research & Development (2017 - 2026)
Arcus Biosciences' Research & Development was $113 million in Q2 2026, down 18.7% from $139 million a year earlier and down 7.4% from the prior quarter.
Powered by 
Analysis
Arcus Biosciences (RCUS) Research & Development (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Arcus Biosciences' Research & Development was $497 million through Jun 30, 2026, up 2.5% year-over-year; for FY2025, it came in at $523 million, up 16.7% from FY2024.
- Research & Development has now increased for nine consecutive years, with a five-year compound annual growth rate of 26.9% (FY2020 to FY2025).
- In earlier years, Research & Development was $448 million in FY2024 (+31.8%), $340 million in FY2023 (+18.1%), $288 million in FY2022 (+12.1%) and $257 million in FY2021 (+61.6%).
- The Q2 2026 figure marks the lowest quarterly Research & Development since Q4 2024.
- Compared with a year earlier, Research & Development was higher in six of the last eight quarters, with growth averaging 13.4%.
- The best year-over-year quarter for Research & Development over five years was Q4 2022 (growth of 58.1%); the worst was Q2 2026 (a decline of 18.7%).
- Per Business Quant data, RCUS's Research & Development in the three quarters before Q2 2026 was $122 million (Q1 2026), $121 million (Q4 2025) and $141 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Arcus Biosciences | 3.18 Bn | -157.19 Mn | - | 113.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 113.00 Mn |
| Mar 31, 2026 | 122.00 Mn |
| Dec 31, 2025 | 121.00 Mn |
| Sep 30, 2025 | 141.00 Mn |
| Jun 30, 2025 | 139.00 Mn |
| Mar 31, 2025 | 122.00 Mn |
| Dec 31, 2024 | 101.00 Mn |
| Sep 30, 2024 | 123.00 Mn |
| Jun 30, 2024 | 115.00 Mn |
| Mar 31, 2024 | 109.00 Mn |
| Dec 31, 2023 | 93.00 Mn |
| Sep 30, 2023 | 82.00 Mn |
| Jun 30, 2023 | 84.00 Mn |
| Mar 31, 2023 | 81.00 Mn |
| Dec 31, 2022 | 80.00 Mn |
| Sep 30, 2022 | 77.00 Mn |
| Jun 30, 2022 | 70.00 Mn |
| Mar 31, 2022 | 61.00 Mn |
| Dec 31, 2021 | 50.59 Mn |
| Sep 30, 2021 | 71.25 Mn |
API Access
Arcus Biosciences Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=RCUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();